PMID- 9919735
OWN - NLM
STAT- MEDLINE
DCOM- 19990222
LR  - 20051116
IS  - 0300-8495 (Print)
IS  - 0300-8495 (Linking)
VI  - 27
IP  - 12
DP  - 1998 Dec
TI  - Long acting beta agonists.
PG  - 1115-8
AB  - Long acting beta agonists (LABAs) such as salmeterol and eformoterol provide 12 
      hour bronchodilatation, giving continuous control of asthma symptoms particularly 
      at night. More recent evidence also suggests a role as 'steroid-sparing' agents, 
      allowing control of asthma at lower doses of inhaled corticosteroids (ICS). 
      Providing a sufficient dose of inhaled steroid (in adults around 800 micrograms 
      of belcomethasone or budesonide or 400 micrograms of fluticasone) is used in 
      conjunction with LABAs, there is no evidence of any increase in asthma 
      exacerbation. Cost is the major impediment to the widespread application of these 
      useful agents.
FAU - Bowler, S
AU  - Bowler S
AD  - Mater Adult Hospital.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Australia
TA  - Aust Fam Physician
JT  - Australian family physician
JID - 0326701
RN  - 0 (Adrenal Cortex Hormones)
RN  - 0 (Adrenergic beta-Agonists)
SB  - IM
MH  - Adrenal Cortex Hormones/administration & dosage
MH  - Adrenergic beta-Agonists/*administration & dosage/adverse effects/pharmacology
MH  - Adult
MH  - Asthma/*drug therapy
MH  - Australia
MH  - Dose-Response Relationship, Drug
MH  - Drug Therapy, Combination
MH  - Humans
MH  - Prognosis
MH  - Treatment Outcome
RF  - 10
EDAT- 1999/01/27 00:00
MHDA- 1999/01/27 00:01
CRDT- 1999/01/27 00:00
PHST- 1999/01/27 00:00 [pubmed]
PHST- 1999/01/27 00:01 [medline]
PHST- 1999/01/27 00:00 [entrez]
PST - ppublish
SO  - Aust Fam Physician. 1998 Dec;27(12):1115-8.